| Year |
Citation |
Score |
| 2021 |
Leonard MM, Colwell RR, Fasano A. Reply to Chen and Vitetta: Unraveling the complex interactions among organisms in the microbiome is necessary to identify unique signatures predicting CD onset. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34607963 DOI: 10.1073/pnas.2114053118 |
0.312 |
|
| 2021 |
Leonard MM, Valitutti F, Karathia H, Pujolassos M, Kenyon V, Fanelli B, Troisi J, Subramanian P, Camhi S, Colucci A, Serena G, Cucchiara S, Trovato CM, Malamisura B, Francavilla R, ... ... Fasano A, et al. Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34253606 DOI: 10.1073/pnas.2020322118 |
0.404 |
|
| 2020 |
Leonard MM, Karathia H, Pujolassos M, Troisi J, Valitutti F, Subramanian P, Camhi S, Kenyon V, Colucci A, Serena G, Cucchiara S, Montuori M, Malamisura B, Francavilla R, Elli L, ... ... Fasano A, et al. Multi-omics analysis reveals the influence of genetic and environmental risk factors on developing gut microbiota in infants at risk of celiac disease. Microbiome. 8: 130. PMID 32917289 DOI: 10.1186/S40168-020-00906-W |
0.449 |
|
| 2020 |
Heickman LKW, DeBoer MD, Fasano A. Zonulin as a potential putative biomarker of risk for shared Type 1 Diabetes and Celiac disease Autoimmunity Diabetes-Metabolism Research and Reviews. 36. PMID 32162764 DOI: 10.1002/Dmrr.3309 |
0.357 |
|
| 2020 |
Fasano A. All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000research. 9: 69. PMID 32051759 DOI: 10.12688/F1000Research.20510.1 |
0.358 |
|
| 2019 |
Verma S, Prescott RA, Ingano L, Nickerson KP, Hill E, Faherty CS, Fasano A, Senger S, Cherayil BJ. The YrbE phospholipid transporter of serovar Typhi regulates the expression of flagellin and influences motility, adhesion and induction of epithelial inflammatory responses. Gut Microbes. 1-13. PMID 31829769 DOI: 10.1080/19490976.2019.1697593 |
0.332 |
|
| 2019 |
Serena G, Huynh D, Lima RS, Vise LM, Freire R, Ingano L, Leonard MM, Senger S, Fasano A. Intestinal Epithelium Modulates Macrophage Response to Gliadin in Celiac Disease. Frontiers in Nutrition. 6: 167. PMID 31750310 DOI: 10.3389/Fnut.2019.00167 |
0.334 |
|
| 2019 |
Miranda-Ribera A, Ennamorati M, Serena G, Cetinbas M, Lan J, Sadreyev RI, Jain N, Fasano A, Fiorentino M. Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles. Frontiers in Immunology. 10: 2233. PMID 31608059 DOI: 10.3389/Fimmu.2019.02233 |
0.344 |
|
| 2019 |
Valitutti F, Cucchiara S, Fasano A. Celiac Disease and the Microbiome. Nutrients. 11: 2403. PMID 31597349 DOI: 10.3390/Nu11102403 |
0.348 |
|
| 2019 |
Noval Rivas M, Wakita D, Franklin MK, Carvalho TT, Abolhesn A, Gomez AC, Fishbein MC, Chen S, Lehman TJ, Sato K, Shibuya A, Fasano A, Kiyono H, Abe M, Tatsumoto N, et al. Intestinal Permeability and IgA Provoke Immune Vasculitis Linked to Cardiovascular Inflammation. Immunity. PMID 31471109 DOI: 10.1016/J.Immuni.2019.05.021 |
0.311 |
|
| 2019 |
Caio G, Volta U, Sapone A, Leffler DA, Giorgio RD, Catassi C, Fasano A. Celiac Disease: A Comprehensive Current Review Bmc Medicine. 17: 1-20. PMID 31331324 DOI: 10.1186/S12916-019-1380-Z |
0.361 |
|
| 2019 |
Valitutti F, Fasano A. Breaking Down Barriers: How Understanding Celiac Disease Pathogenesis Informed the Development of Novel Treatments. Digestive Diseases and Sciences. 64: 1748-1758. PMID 31076989 DOI: 10.1007/S10620-019-05646-Y |
0.38 |
|
| 2019 |
Freire R, Ingano L, Serena G, Cetinbas M, Anselmo A, Sapone A, Sadreyev RI, Fasano A, Senger S. Human gut derived-organoids provide model to study gluten response and effects of microbiota-derived molecules in celiac disease. Scientific Reports. 9: 7029. PMID 31065051 DOI: 10.1038/S41598-019-43426-W |
0.344 |
|
| 2019 |
Serena G, Kelly CP, Fasano A. Nondietary Therapies for Celiac Disease Gastroenterology Clinics of North America. 48: 145-163. PMID 30711207 DOI: 10.1016/J.Gtc.2018.09.011 |
0.313 |
|
| 2019 |
Serena G, Huynh D, Lima R, Ingano L, Freire R, Senger S, Fasano A. Mo1250 – Contribution of the Intestinal Epithelium in Modulating Macrophage Response to Pt-Gliadin in Celiac Disease Gastroenterology. 156. DOI: 10.1016/S0016-5085(19)38765-7 |
0.31 |
|
| 2019 |
Miranda-Ribera A, Ennamorati MT, Serena G, Jain N, Lan J, Sadreyev RI, Cetinbas M, Fasano A, Fiorentino MR. Sa1739 – Using the Zonulin Transgenic Mouse Model to Understand the Interplay Between Gut Permeability, Immune System, and Microbiota in the Context of Gut Inflammatory Diseases Gastroenterology. 156: S-382-S-383. DOI: 10.1016/S0016-5085(19)37806-0 |
0.333 |
|
| 2019 |
Leonard MM, Subramanian P, Valitutti F, Serena G, Kenyon V, Camhi S, Piemontese P, Trovato CM, Raguseo CL, Passaro T, Montuori M, Malamisura B, Francavilla R, Elli L, Cucchiara S, ... ... Fasano A, et al. 820 – Prospective Longitudinal Gut Metagenomic Analysis Suggests Altered Microbiome Composition and Function in Infants Prior to Celiac Disease Onset Gastroenterology. 156: S-175. DOI: 10.1016/S0016-5085(19)37228-2 |
0.427 |
|
| 2019 |
Serena G, Davies C, Cetinbas M, Sadreyev RI, Fasano A. Analysis of blood and fecal microbiome profile in patients with celiac disease Human Microbiome Journal. 11: 100049. DOI: 10.1016/J.Humic.2018.12.001 |
0.332 |
|
| 2018 |
Serena G, Fasano A. Use of Probiotics to Prevent Celiac Disease and IBD in Pediatrics. Advances in Experimental Medicine and Biology. 1125: 69-81. PMID 30565165 DOI: 10.1007/5584_2018_317 |
0.35 |
|
| 2018 |
Ma B, McComb E, Gajer P, Yang H, Humphrys M, Okogbule-Wonodi AC, Fasano A, Ravel J, Viscardi RM. Microbial Biomarkers of Intestinal Barrier Maturation in Preterm Infants. Frontiers in Microbiology. 9: 2755. PMID 30487786 DOI: 10.3389/Fmicb.2018.02755 |
0.314 |
|
| 2018 |
Salerno-Gonçalves R, Galen JE, Levine MM, Fasano A, Sztein MB. Manipulation of Typhi Gene Expression Impacts Innate Cell Responses in the Human Intestinal Mucosa. Frontiers in Immunology. 9: 2543. PMID 30443257 DOI: 10.3389/Fimmu.2018.02543 |
0.654 |
|
| 2018 |
Llanos-Chea A, Citorik RJ, Nickerson KP, Ingano L, Serena G, Senger S, Lu TK, Fasano A, Faherty CS. Bacteriophage Therapy Testing against Shigella flexneri in a Novel Human Intestinal Organoid-Derived Infection Model. Journal of Pediatric Gastroenterology and Nutrition. PMID 30418409 DOI: 10.1097/Mpg.0000000000002203 |
0.305 |
|
| 2018 |
Senger S, Ingano L, Freire R, Anselmo A, Zhu W, Sadreyev R, Walker WA, Fasano A. Human Fetal-Derived Enterospheres Provide Insights on Intestinal Development and a Novel Model to Study Necrotizing Enterocolitis (NEC). Cellular and Molecular Gastroenterology and Hepatology. 5: 549-568. PMID 29930978 DOI: 10.1016/J.Jcmgh.2018.01.014 |
0.315 |
|
| 2018 |
Zhang Y, Brady A, Jones C, Song Y, Darton TC, Jones C, Blohmke CJ, Pollard AJ, Magder LS, Fasano A, Sztein MB, Fraser CM. Compositional and Functional Differences in the Human Gut Microbiome Correlate with Clinical Outcome following Infection with Wild-Type Salmonella enterica Serovar Typhi. Mbio. 9. PMID 29739901 DOI: 10.1128/Mbio.00686-18 |
0.332 |
|
| 2018 |
Nickerson KP, Senger S, Zhang Y, Lima R, Patel S, Ingano L, Flavahan WA, Kumar DKV, Fraser CM, Faherty CS, Sztein MB, Fiorentino M, Fasano A. Salmonella Typhi Colonization Provokes Extensive Transcriptional Changes Aimed at Evading Host Mucosal Immune Defense During Early Infection of Human Intestinal Tissue. Ebiomedicine. PMID 29735417 DOI: 10.1016/J.Ebiom.2018.04.005 |
0.338 |
|
| 2018 |
Aufiero VR, Fasano A, Mazzarella G. Non‐Celiac Gluten Sensitivity: How Its Gut Immune Activation and Potential Dietary Management Differ from Celiac Disease Molecular Nutrition & Food Research. 62: 1700854. PMID 29578652 DOI: 10.1002/Mnfr.201700854 |
0.358 |
|
| 2017 |
Leonard MM, Cureton P, Fasano A. Indications and Use of the Gluten Contamination Elimination Diet for Patients with Non-Responsive Celiac Disease. Nutrients. 9. PMID 29057833 DOI: 10.3390/Nu9101129 |
0.306 |
|
| 2017 |
Fasano A. Celiac Disease, Gut-Brain Axis, and Behavior: Cause, Consequence, or Merely Epiphenomenon? Pediatrics. 139. PMID 28219968 DOI: 10.1542/Peds.2016-4323 |
0.324 |
|
| 2017 |
Leonard MM, Weir DC, DeGroote M, Mitchell PD, Singh P, Silvester JA, Leichtner AM, Fasano A. Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet. Journal of Pediatric Gastroenterology and Nutrition. 64: 286-291. PMID 28112686 DOI: 10.1097/Mpg.0000000000001460 |
0.307 |
|
| 2017 |
Amon P, Serena G, Fasano A, Walker A, Wade W, Sanderson I. Exclusive Enteral Nutrition Modulates the Microbiota in Childhood Crohn’s Disease Independently of its Effect on Intestinal Inflammation Gastroenterology. 152. DOI: 10.1016/S0016-5085(17)31018-1 |
0.353 |
|
| 2016 |
Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases Tissue Barriers. 4. PMID 28123927 DOI: 10.1080/21688370.2016.1251384 |
0.349 |
|
| 2016 |
Serena G, Yan S, Camhi S, Patel S, Lima RS, Sapone A, Leonard MM, Mukherjee R, Nath BJ, Lammers KM, Fasano A. Pro-inflammatory Cytokine IFNγ and Microbiome-Derived Metabolites Dictate Epigenetic Switch between FOXP3 Isoforms in Celiac Disease: Regulation of FOXP3 isoforms in celiac disease. Clinical and Experimental Immunology. PMID 27936497 DOI: 10.1111/Cei.12911 |
0.345 |
|
| 2016 |
Serena G, Leonard MM, Camhi S, Huedo-Medina TB, Fasano A. [Design of a genomic, environmental, microbial and metabolomic study on celiac disease: an approach to the future of personalized prevention of celiac disease]. Recenti Progressi in Medicina. 107: 320-327. PMID 27362724 DOI: 10.1701/2296.24694 |
0.323 |
|
| 2016 |
Shea-Donohue T, Fasano A, Zhao A, Notari L, Yan S, Sun R, Bohl JA, Desai N, Tudor G, Morimoto M, Booth C, Bennett A, Farese AM, MacVittie TJ. Mechanisms Involved in the Development of the Chronic Gastrointestinal Syndrome in Nonhuman Primates after Total-Body Irradiation with Bone Marrow Shielding. Radiation Research. PMID 27223826 DOI: 10.1667/Rr14024.1 |
0.309 |
|
| 2016 |
Salerno-Goncalves R, Safavie F, Fasano A, Sztein MB. Free and complexed-secretory immunoglobulin A triggers distinct intestinal epithelial responses. Clinical and Experimental Immunology. PMID 27084834 DOI: 10.1111/Cei.12801 |
0.331 |
|
| 2015 |
Senger S, Sapone A, Fiorentino MR, Mazzarella G, Lauwers GY, Fasano A. Celiac Disease Histopathology Recapitulates Hedgehog Downregulation, Consistent with Wound Healing Processes Activation. Plos One. 10: e0144634. PMID 26649570 DOI: 10.1371/Journal.Pone.0144634 |
0.347 |
|
| 2015 |
Leonard MM, Camhi S, Huedo-Medina TB, Fasano A. Celiac Disease Genomic, Environmental, Microbiome, and Metabolomic (CDGEMM) Study Design: Approach to the Future of Personalized Prevention of Celiac Disease. Nutrients. 7: 9325-36. PMID 26569299 DOI: 10.3390/Nu7115470 |
0.331 |
|
| 2015 |
Serena G, Camhi S, Sturgeon C, Yan S, Fasano A. The Role of Gluten in Celiac Disease and Type 1 Diabetes. Nutrients. 7: 7143-62. PMID 26343710 DOI: 10.3390/Nu7095329 |
0.335 |
|
| 2015 |
Leffler DA, Green PH, Fasano A. Extraintestinal manifestations of coeliac disease. Nature Reviews. Gastroenterology & Hepatology. 12: 561-71. PMID 26260366 DOI: 10.1038/Nrgastro.2015.131 |
0.307 |
|
| 2015 |
Lebwohl B, Murray JA, Verdú EF, Crowe SE, Dennis M, Fasano A, Green PH, Guandalini S, Khosla C. Gluten Introduction, Breastfeeding, and Celiac Disease: Back to the Drawing Board. The American Journal of Gastroenterology. PMID 26259710 DOI: 10.1038/Ajg.2015.219 |
0.337 |
|
| 2015 |
Rawal N, Twaddell W, Fasano A, Blanchard S, Safta A. Remission of Refractory Celiac Disease With Infliximab in a Pediatric Patient. Acg Case Reports Journal. 2: 121-3. PMID 26157934 DOI: 10.14309/Crj.2015.25 |
0.318 |
|
| 2015 |
Hollon J, Puppa EL, Greenwald B, Goldberg E, Guerrerio A, Fasano A. Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity. Nutrients. 7: 1565-76. PMID 25734566 DOI: 10.3390/Nu7031565 |
0.312 |
|
| 2014 |
Barada K, Habib RH, Malli A, Hashash JG, Halawi H, Maasri K, Tawil A, Mourad F, Sharara AI, Soweid A, Sukkarieh I, Chakhachiro Z, Jabbour M, Fasano A, Santora D, et al. Prediction of celiac disease at endoscopy. Endoscopy. 46: 110-9. PMID 24477366 DOI: 10.1055/S-0033-1359200 |
0.304 |
|
| 2014 |
Fiorentino M, Levine MM, Sztein MB, Fasano A. Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release. Plos One. 9: e85211. PMID 24416363 DOI: 10.1371/Journal.Pone.0085211 |
0.37 |
|
| 2013 |
Catassi C, Bai JC, Bonaz B, Bouma G, Calabrò A, Carroccio A, Castillejo G, Ciacci C, Cristofori F, Dolinsek J, Francavilla R, Elli L, Green P, Holtmeier W, Koehler P, ... ... Fasano A, et al. Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders. Nutrients. 5: 3839-53. PMID 24077239 DOI: 10.3390/Nu5103839 |
0.325 |
|
| 2013 |
Alaish SM, Smith AD, Timmons J, Greenspon J, Eyvazzadeh D, Murphy E, Shea-Donahue T, Cirimotich S, Mongodin E, Zhao A, Fasano A, Nataro JP, Cross A. Gut microbiota, tight junction protein expression, intestinal resistance, bacterial translocation and mortality following cholestasis depend on the genetic background of the host. Gut Microbes. 4: 292-305. PMID 23652772 DOI: 10.4161/Gmic.24706 |
0.489 |
|
| 2013 |
Fiorentino M, Lammers KM, Levine MM, Sztein MB, Fasano A. In vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid Vaccines. Frontiers in Immunology. 4: 17. PMID 23408152 DOI: 10.3389/Fimmu.2013.00017 |
0.312 |
|
| 2013 |
Bai JC, Fried M, Corazza GR, Schuppan D, Farthing M, Catassi C, Greco L, Cohen H, Ciacci C, Eliakim R, Fasano A, González A, Krabshuis JH, LeMair A. World Gastroenterology Organisation global guidelines on celiac disease. Journal of Clinical Gastroenterology. 47: 121-6. PMID 23314668 DOI: 10.1097/Mcg.0B013E31827A6F83 |
0.324 |
|
| 2013 |
Faherty CS, Harper JM, Shea-Donohue T, Barry EM, Kaper JB, Fasano A, Nataro JP. Correction: Chromosomal and plasmid-encoded factors of Shigella flexneri induce secretogenic activity ex vivo (PLoS ONE) Plos One. 8. DOI: 10.1371/Annotation/44400281-2456-4853-A89B-4Dea4F9Aa27B |
0.584 |
|
| 2013 |
Fiorentino MR, Lammers KM, Sztein M, Fasano A. Tu1721 Shigella Spp. Adversely Affect Paracellular Permeability in In Vitro and Ex-Vivo Models of Intestinal Mucosa Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)63085-1 |
0.303 |
|
| 2013 |
Fiorentino MR, Ding H, Blanchard TG, Sztein M, Fasano A. Tu1712 Helicobacter pylori Affects Gastric Epithelial Barrier Integrity Independent of Its Main Virulence Factors and Induces a Polarized Host Inflammatory Cytokine Secretion in an In Vitro Human Cell Model Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)63076-0 |
0.326 |
|
| 2013 |
Hollon JR, Puppa ELL, Greenwald BD, Goldberg EM, Guerrerio AL, Fasano A. Sa2009 Effect of Gliadin on Permeability of Intestinal Biopsy Explants From Celiac Disease Patients Gastroenterology. 144: S-358. DOI: 10.1016/S0016-5085(13)61318-9 |
0.342 |
|
| 2012 |
Faherty CS, Faherty C, Harper JM, Shea-Donohue T, Barry EM, Kaper JB, Fasano A, Nataro JP. Chromosomal and plasmid-encoded factors of Shigella flexneri induce secretogenic activity ex vivo. Plos One. 7: e49980. PMID 23166804 DOI: 10.1371/Journal.Pone.0049980 |
0.633 |
|
| 2012 |
Fasano A. Novel therapeutic/integrative approaches for celiac disease and dermatitis herpetiformis. Clinical & Developmental Immunology. 2012: 959061. PMID 23093980 DOI: 10.1155/2012/959061 |
0.328 |
|
| 2012 |
Fasano A. Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 10: 1096-100. PMID 22902773 DOI: 10.1016/J.Cgh.2012.08.012 |
0.334 |
|
| 2012 |
Fasano A. Zonulin, regulation of tight junctions, and autoimmune diseases. Annals of the New York Academy of Sciences. 1258: 25-33. PMID 22731712 DOI: 10.1111/J.1749-6632.2012.06538.X |
0.36 |
|
| 2012 |
Rossi F, Bellini G, Tolone C, Luongo L, Mancusi S, Papparella A, Sturgeon C, Fasano A, Nobili B, Perrone L, Maione S, del Giudice EM. The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention. Pharmacological Research. 66: 88-94. PMID 22465144 DOI: 10.1016/J.Phrs.2012.03.011 |
0.321 |
|
| 2012 |
Sellitto M, Bai G, Serena G, Fricke WF, Sturgeon C, Gajer P, White JR, Koenig SS, Sakamoto J, Boothe D, Gicquelais R, Kryszak D, Puppa E, Catassi C, Ravel J, ... Fasano A, et al. Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. Plos One. 7: e33387. PMID 22432018 DOI: 10.1371/Journal.Pone.0033387 |
0.305 |
|
| 2012 |
Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M, Kaukinen K, Rostami K, Sanders DS, Schumann M, Ullrich R, Villalta D, Volta U, Catassi C, Fasano A. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. Bmc Medicine. 10: 13. PMID 22313950 DOI: 10.1186/1741-7015-10-13 |
0.302 |
|
| 2012 |
Fasano A. Leaky gut and autoimmune diseases. Clinical Reviews in Allergy & Immunology. 42: 71-8. PMID 22109896 DOI: 10.1007/S12016-011-8291-X |
0.37 |
|
| 2012 |
Netzel-Arnett S, Buzza MS, Shea-Donohue T, Désilets A, Leduc R, Fasano A, Bugge TH, Antalis TM. Matriptase protects against experimental colitis and promotes intestinal barrier recovery. Inflammatory Bowel Diseases. 18: 1303-14. PMID 22081509 DOI: 10.1002/Ibd.21930 |
0.329 |
|
| 2012 |
Jackson JR, Eaton WW, Cascella NG, Fasano A, Kelly DL. Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. The Psychiatric Quarterly. 83: 91-102. PMID 21877216 DOI: 10.1007/S11126-011-9186-Y |
0.344 |
|
| 2012 |
Sapone A, Picardi A, Siniscalco D, Angrisani D, Iardino P, Bravaccio C, Riegler G, Cariello R, Magistris Ld, Fasano A. Su2077 Antibodies Against Alfa Gliadin (AGA) and Deamidated Gliadin Peptides (DGP) in Patients With Autistic Spectrum Disorder (ASD) Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)62165-9 |
0.315 |
|
| 2011 |
Nair PP, Kamra A, Kessie G, Kalavapudi S, Chen JH, Shores R, Madairos L, Fasano A, Nair P. Markers of Inflammation and Lineage on Exfoliated Colonic Cells In Pediatric Inflammatory Bowel Disease. Journal of Gastrointestinal & Digestive System. 8: 1-6. PMID 23519721 DOI: 10.4172/2161-069X.S8-001 |
0.324 |
|
| 2011 |
Sapone A, Lammers KM, Casolaro V, Cammarota M, Giuliano MT, De Rosa M, Stefanile R, Mazzarella G, Tolone C, Russo MI, Esposito P, Ferraraccio F, Cartenì M, Riegler G, de Magistris L, ... Fasano A, et al. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. Bmc Medicine. 9: 23. PMID 21392369 DOI: 10.1186/1741-7015-9-23 |
0.336 |
|
| 2010 |
Catassi C, Kryszak D, Bhatti B, Sturgeon C, Helzlsouer K, Clipp SL, Gelfond D, Puppa E, Sferruzza A, Fasano A. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Annals of Medicine. 42: 530-8. PMID 20868314 DOI: 10.3109/07853890.2010.514285 |
0.313 |
|
| 2010 |
Catassi C, Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. The American Journal of Medicine. 123: 691-3. PMID 20670718 DOI: 10.1016/J.Amjmed.2010.02.019 |
0.325 |
|
| 2010 |
Fasano A, Counts D. Commentary on "anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear growth". The American Journal of Gastroenterology. 105: 697-8. PMID 20203647 DOI: 10.1038/Ajg.2009.640 |
0.3 |
|
| 2010 |
Buzza MS, Netzel-Arnett S, Shea-Donohue T, Zhao A, Lin CY, List K, Szabo R, Fasano A, Bugge TH, Antalis TM. Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. Proceedings of the National Academy of Sciences of the United States of America. 107: 4200-5. PMID 20142489 DOI: 10.1073/Pnas.0903923107 |
0.322 |
|
| 2010 |
Sapone A, Lammers KM, Mazzarella G, Mikhailenko I, Cartenì M, Casolaro V, Fasano A. Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. International Archives of Allergy and Immunology. 152: 75-80. PMID 19940509 DOI: 10.1159/000260087 |
0.335 |
|
| 2009 |
Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, Antalis TM, Vogel SN, Zhao A, Yang S, Arrietta MC, Meddings JB, Fasano A. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proceedings of the National Academy of Sciences of the United States of America. 106: 16799-804. PMID 19805376 DOI: 10.1073/Pnas.0906773106 |
0.338 |
|
| 2009 |
Fasano A. Surprises from celiac disease. Scientific American. 301: 54-61. PMID 19634568 DOI: 10.1038/Scientificamerican0809-54 |
0.31 |
|
| 2009 |
Visser J, Rozing J, Sapone A, Lammers K, Fasano A. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Annals of the New York Academy of Sciences. 1165: 195-205. PMID 19538307 DOI: 10.1111/J.1749-6632.2009.04037.X |
0.359 |
|
| 2009 |
Lu R, Fasano S, Madayiputhiya N, Morin NP, Nataro J, Fasano A. Isolation, identification, and characterization of small bioactive peptides from Lactobacillus GG conditional media that exert both anti-Gram-negative and Gram-positive bactericidal activity. Journal of Pediatric Gastroenterology and Nutrition. 49: 23-30. PMID 19465870 DOI: 10.1097/Mpg.0B013E3181924D1E |
0.521 |
|
| 2009 |
Alaish SM, Greenspon J, Eyvazzadeh D, Shea-Donohue T, Cross A, Fasano A, Nataro JP. M1703 Intestinal Permeability and Bacterial Translocation Are Modulated By the Genetic Background of the Host Gastroenterology. 136: A-414. DOI: 10.1016/S0016-5085(09)61903-X |
0.485 |
|
| 2008 |
Fasano A. Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. The American Journal of Pathology. 173: 1243-52. PMID 18832585 DOI: 10.2353/Ajpath.2008.080192 |
0.371 |
|
| 2008 |
Lammers KM, Lu R, Brownley J, Lu B, Gerard C, Thomas K, Rallabhandi P, Shea-Donohue T, Tamiz A, Alkan S, Netzel-Arnett S, Antalis T, Vogel SN, Fasano A. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology. 135: 194-204.e3. PMID 18485912 DOI: 10.1053/J.Gastro.2008.03.023 |
0.358 |
|
| 2007 |
Paterson BM, Lammers KM, Arrieta MC, Fasano A, Meddings JB. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. Alimentary Pharmacology & Therapeutics. 26: 757-66. PMID 17697209 DOI: 10.1111/J.1365-2036.2007.03413.X |
0.314 |
|
| 2007 |
Antalis TM, Shea-Donohue T, Vogel SN, Sears C, Fasano A. Mechanisms of disease: protease functions in intestinal mucosal pathobiology. Nature Clinical Practice. Gastroenterology & Hepatology. 4: 393-402. PMID 17607295 DOI: 10.1038/Ncpgasthep0846 |
0.351 |
|
| 2006 |
Branski D, Fasano A, Troncone R. Latest developments in the pathogenesis and treatment of celiac disease The Journal of Pediatrics. 149: 295-300. PMID 16939736 DOI: 10.1016/J.Jpeds.2006.06.003 |
0.322 |
|
| 2006 |
Motlekar NA, Fasano A, Wachtel MS, Youan BBC. Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin Journal of Drug Targeting. 14: 321-329. PMID 16882552 DOI: 10.1080/10611860600613316 |
0.314 |
|
| 2006 |
Sapone A, Magistris LD, Pietzak MM, Clemente MG, Tripathi A, Cucca F, Lampis R, Kryszak D, Cartenì M, Generoso M, Iafusco D, Prisco F, Laghi F, Riegler G, Carratù R, ... ... Fasano A, et al. Zonulin Upregulation Is Associated With Increased Gut Permeability in Subjects With Type 1 Diabetes and Their Relatives Diabetes. 55: 1443-1449. PMID 16644703 DOI: 10.2337/Db05-1593 |
0.305 |
|
| 2006 |
Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Tripathi A, Sapone A, Thakar M, Iacono G, Carroccio A, D'Agate C, Not T, Zampini L, Catassi C, Fasano A. Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scandinavian Journal of Gastroenterology. 41: 408-19. PMID 16635908 DOI: 10.1080/00365520500235334 |
0.32 |
|
| 2006 |
Thomas KE, Sapone A, Fasano A, Vogel SN. Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease. Journal of Immunology (Baltimore, Md. : 1950). 176: 2512-21. PMID 16456012 DOI: 10.4049/Jimmunol.176.4.2512 |
0.342 |
|
| 2006 |
Fasano A. Regulation of Intercellular Tight Junctions by Zonula Occludens Toxin and Its Eukaryotic Analogue Zonulin Annals of the New York Academy of Sciences. 915: 214-222. PMID 11193578 DOI: 10.1111/J.1749-6632.2000.Tb05244.X |
0.347 |
|
| 2006 |
Tripathi A, Clemente MG, Sapone A, Musu MP, Virgiliis SD, Fasano A. Expression Of Tight Junction Proteins In Diseases With Compromised Intestinal Barrier Function Journal of Pediatric Gastroenterology and Nutrition. 43. DOI: 10.1097/00005176-200610000-00029 |
0.304 |
|
| 2005 |
Gadewar S, Fasano A. Celiac disease: is the atypical really typical? Summary of the recent National Institutes of Health Consensus Conference and latest advances. Current Gastroenterology Reports. 7: 455-461. PMID 16313875 DOI: 10.1007/S11894-005-0076-Z |
0.315 |
|
| 2005 |
Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nature Clinical Practice. Gastroenterology & Hepatology. 2: 416-22. PMID 16265432 DOI: 10.1038/Ncpgasthep0259 |
0.376 |
|
| 2005 |
Gadewar S, Fasano A. Current concepts in the evaluation, diagnosis and management of acute infectious diarrhea. Current Opinion in Pharmacology. 5: 559-565. PMID 16207535 DOI: 10.1016/J.Coph.2005.08.002 |
0.329 |
|
| 2005 |
Taddei CR, Fasano A, Ferreira AJ, Trabulsi LR, Martinez MB. Secreted autotransporter toxin produced by a diffusely adhering Escherichia coli strain causes intestinal damage in animal model assays. Fems Microbiology Letters. 250: 263-9. PMID 16098687 DOI: 10.1016/J.Femsle.2005.07.013 |
0.329 |
|
| 2005 |
Fasano A, Catassi C. Coeliac disease in children Best Practice & Research in Clinical Gastroenterology. 19: 467-478. PMID 15925850 DOI: 10.1016/J.Bpg.2005.01.008 |
0.31 |
|
| 2005 |
Fasano A. Clinical presentation of celiac disease in the pediatric population. Gastroenterology. 128. PMID 15825129 DOI: 10.1053/J.Gastro.2005.02.015 |
0.308 |
|
| 2004 |
Catassi C, Fasano A. Celiac disease as a cause of growth retardation in childhood. Current Opinion in Pediatrics. 16: 445-449. PMID 15273508 DOI: 10.1097/01.Mop.0000133637.64414.20 |
0.35 |
|
| 2004 |
Salazar-Lindo E, Allen S, Brewster DR, Elliott EJ, Fasano A, Phillips AD, Sanderson IR, Tarr PI. Intestinal infections and environmental enteropathy: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastroenterology and Nutrition. 39: S662-9. PMID 15184767 DOI: 10.1097/00005176-200406002-00013 |
0.308 |
|
| 2004 |
Fasano A, Nataro JP. Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins. Advanced Drug Delivery Reviews. 56: 795-807. PMID 15063590 DOI: 10.1016/J.Addr.2003.10.045 |
0.544 |
|
| 2004 |
Fasano A, Watts T, Sapone A, Zielke R. P0086 Pp Zonulin-Dependent Increased Intestinal Permeability Is Involved In The Pathogenesis Of Type 1 Diabetes And Can Be Blocked To Prevent The Onset Of The Disease Journal of Pediatric Gastroenterology and Nutrition. 39. DOI: 10.1097/00005176-200406001-00210 |
0.302 |
|
| 2003 |
Fasano A. Celiac Disease — How to Handle a Clinical Chameleon The New England Journal of Medicine. 348: 2568-2570. PMID 12815143 DOI: 10.1056/Nejme030050 |
0.336 |
|
| 2003 |
Marinaro M, Fasano A, Magistris MTD. Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responses. Infection and Immunity. 71: 1897-1902. PMID 12654806 DOI: 10.1128/Iai.71.4.1897-1902.2003 |
0.304 |
|
| 2003 |
Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PH, Guandalini S, Hill ID, Pietzak M, Ventura A, Thorpe M, Kryszak D, Fornaroli F, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Archives of Internal Medicine. 163: 286-92. PMID 12578508 DOI: 10.1001/Archinte.163.3.286 |
0.302 |
|
| 2003 |
Clemente MG, De Virgiliis S, Kang JS, Macatagney R, Musu MP, Di Pierro MR, Drago S, Congia M, Fasano A. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function Gut. 52: 218-223. PMID 12524403 DOI: 10.1136/Gut.52.2.218 |
0.355 |
|
| 2003 |
Fasano A. European and North American populations should be screened for coeliac disease. Gut. 52: 168-169. PMID 12524393 DOI: 10.1136/Gut.52.2.168 |
0.326 |
|
| 2003 |
Clemente MG, Musu MP, Troncone R, Ciacci C, Not T, Neri E, Strisciuglio P, Maggiore G, Cicotto L, Sole G, Gasbarrini G, Corazza GR, Volta U, Fasano A, Virgiliis SD. Detection of autoantibodies against enterocyte actin filaments as serological predictive test for intestinal villous atrophy in celiac disease: Results of a polycentric study Gastroenterology. 124. DOI: 10.1016/S0016-5085(03)83343-7 |
0.301 |
|
| 2003 |
Drago S, Asmar RE, D'Agate C, Iacono G, Pierro MD, Catassi C, Fasano A. Gliadin induces a zonulin-dependent increased intestinal permeability and decreased expression of tight junction proteins in an ex-vivo human intestinal model of celiac disease The American Journal of Gastroenterology. 98. DOI: 10.1016/S0002-9270(03)01461-8 |
0.347 |
|
| 2002 |
Asmar RE, Panigrahi P, Bamford P, Berti I, Not T, Coppa GV, Catassi C, Fasano A. Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure Gastroenterology. 123: 1607-1615. PMID 12404235 DOI: 10.1053/Gast.2002.36578 |
0.355 |
|
| 2002 |
Catassi C, Fasano A. New developments in childhood celiac disease. Current Gastroenterology Reports. 4: 238-243. PMID 12010625 DOI: 10.1007/S11894-002-0069-0 |
0.31 |
|
| 2002 |
Fasano A. Toxins and the gut: role in human disease. Gut. 50. PMID 11953326 DOI: 10.1136/Gut.50.Suppl_3.Iii9 |
0.334 |
|
| 2002 |
Rossi M, Maurano F, Luongo D, Fasano A, Uzzau S, Auricchio S, Troncone R. Zonula occludens toxin (Zot) interferes with the induction of nasal tolerance to gliadin. Immunology Letters. 81: 217-221. PMID 11947928 DOI: 10.1016/S0165-2478(02)00038-X |
0.314 |
|
| 2002 |
Drago S, Di Pierro M, Catassi C, Fasano A. Recent developments in the pathogenesis, diagnosis and treatment of celiac disease Expert Opinion On Therapeutic Patents. 12: 45-51. DOI: 10.1517/13543776.12.1.45 |
0.334 |
|
| 2002 |
Catassi C, Fornaroli F, Fasano A. Celiac disease: From basic immunology to bedside practice Clinical and Applied Immunology Reviews. 3: 61-71. DOI: 10.1016/S1529-1049(02)00060-0 |
0.33 |
|
| 2001 |
Fasano A. Bacterial infections: small intestine and colon. Current Opinion in Gastroenterology. 17: 4-9. PMID 17031142 DOI: 10.1097/00001574-200101000-00002 |
0.317 |
|
| 2001 |
Fasano A. Intestinal zonulin: open sesame! Gut. 49: 159-162. PMID 11454785 DOI: 10.1136/Gut.49.2.159 |
0.319 |
|
| 2001 |
Fasano A. Celiac disease: the past, the present, the future. Pediatrics. 107: 768-770. PMID 11335755 DOI: 10.1542/Peds.107.4.768 |
0.35 |
|
| 2001 |
Raimondi F, Kaper JB, Boedeker EC, Wolf MK, Guandalini S, Fasano A. Enteropathogenic Escherichia coli strain RDEC-1 produces a novel electrogenic factor active on rabbit ileum in vitro. Journal of Pediatric Gastroenterology and Nutrition. 32: 122-126. PMID 11321378 DOI: 10.1097/00005176-200102000-00005 |
0.519 |
|
| 2001 |
Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum☆ Gastroenterology. 120: 636-651. PMID 11179241 DOI: 10.1053/Gast.2001.22123 |
0.351 |
|
| 2001 |
Pietzak MM, Catassi C, Drago S, Fornaroli F, Fasano A. Celiac Disease: Going Against the Grains Nutrition in Clinical Practice. 16: 335-344. DOI: 10.1177/088453360101600606 |
0.34 |
|
| 2001 |
Wilson KT, Gobert AP, Cheng Y, Akhtar M, Newton JC, Rhee SJ, Nataro JP, Fasano A. Shigella enterotoxin 1-stimulated intestinal secretion is mediated by inducible nitric oxide synthase Gastroenterology. 120: A109. DOI: 10.1016/S0016-5085(08)80535-5 |
0.477 |
|
| 2000 |
Uzzau S, Fasano A. Cross‐talk between enteric pathogens and the intestine Cellular Microbiology. 2: 83-89. PMID 11207565 DOI: 10.1046/J.1462-5822.2000.00041.X |
0.335 |
|
| 2000 |
Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease The Lancet. 355: 1518-1519. PMID 10801176 DOI: 10.1016/S0140-6736(00)02169-3 |
0.36 |
|
| 2000 |
Hill I, Fasano A, Schwartz R, Counts D, Glock M, Horvath K. The prevalence of celiac disease in at-risk groups of children in the United States Journal of Pediatrics. 136: 86-90. PMID 10636980 DOI: 10.1016/S0022-3476(00)90055-6 |
0.306 |
|
| 2000 |
Asmar RE, Paningrahi P, Bamford P, Berti I, Not T, Catassi C, Coppa GV, Fasano A. Zonulin is involved in the impairment of the gut barrier function following small intestinal bacterial colonization Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)85402-5 |
0.318 |
|
| 2000 |
Asmar RE, Fasano A, Bamford P, Berti I, Not T, Catassi C, Coppa GV, Panigrahi P. Probiotics prevent zonulin-mediated intestinal barrier dysfunction secondary to bacterial colonization Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)85401-3 |
0.331 |
|
| 2000 |
Sblattero D, Berti I, Trevisiol C, Marzari R, Tommasini A, Bradbury A, Fasano A, Ventura A, Not T. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease The American Journal of Gastroenterology. 95: 1253-1257. DOI: 10.1016/S0002-9270(00)00810-8 |
0.323 |
|
| 1999 |
Fabbri A, Falzano L, Frank C, Donelli G, Matarrese P, Raimondi F, Fasano A, Fiorentini C. Vibrio parahaemolyticus Thermostable Direct Hemolysin Modulates Cytoskeletal Organization and Calcium Homeostasis in Intestinal Cultured Cells Infection and Immunity. 67: 1139-1148. PMID 10024554 DOI: 10.1128/Iai.67.3.1139-1148.1999 |
0.316 |
|
| 1999 |
Sulakvelidze A, Kreger A, Joseph A, Robins-Browne RM, Fasano A, Wauters G, Harnett N, DeTolla L, Morris JG. Production of enterotoxin by Yersinia bercovieri, a recently identified Yersinia enterocolitica-like species. Infection and Immunity. 67: 968-71. PMID 9916117 DOI: 10.1128/Iai.67.2.968-971.1999 |
0.348 |
|
| 1999 |
Marinaro M, Tommaso Ad, Uzzau S, Fasano A, Magistris MTd. Zonula Occludens Toxin Is a Powerful Mucosal Adjuvant for Intranasally Delivered Antigens Infection and Immunity. 67: 1287-1291. DOI: 10.1128/Iai.67.3.1287-1291.1999 |
0.322 |
|
| 1999 |
Not T, Berti I, Fasano A, Citta A, Ventura A. Role of zonulin in the intestinal permeability changes typical of the acute phase of coeliac disease. Journal of Pediatric Gastroenterology and Nutrition. 28: 563. DOI: 10.1097/00005176-199905000-00100 |
0.301 |
|
| 1998 |
Fasano A. Modulation of intestinal permeability: an innovative method of oral drug delivery for the treatment of inherited and acquired human diseases. Molecular Genetics and Metabolism. 64: 12-18. PMID 9682213 DOI: 10.1006/Mgme.1998.2667 |
0.3 |
|
| 1998 |
Maurelli AT, Fernández RE, Bloch CA, Rode CK, Fasano A. "Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America. 95: 3943-8. PMID 9520472 DOI: 10.1073/Pnas.95.7.3943 |
0.301 |
|
| 1997 |
Trucksis M, Conn TL, Fasano A, Kaper JB. Production of Vibrio cholerae accessory cholera enterotoxin (Ace) in the yeast Pichia pastoris. Infection and Immunity. 65: 4984-4988. PMID 9393786 DOI: 10.1128/Iai.65.12.4984-4988.1997 |
0.496 |
|
| 1997 |
Mynott TL, Guandalini S, Raimondi F, Fasano A. Bromelain prevents secretion caused by Vibrio cholerae and Escherichia coli enterotoxins in rabbit ileum in vitro. Gastroenterology. 113: 175-184. PMID 9207276 DOI: 10.1016/S0016-5085(97)70093-3 |
0.309 |
|
| 1997 |
Fasano A, Noriega FR, Liao FM, Wang W, Levine MM. Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo Gut. 40: 505-511. PMID 9176079 DOI: 10.1136/Gut.40.4.505 |
0.301 |
|
| 1997 |
Fasano A, Uzzau S, Fiore C, Margaretten K. The enterotoxic effect of zonula occludens toxin on rabbit small intestine involves the paracellular pathway Gastroenterology. 112: 839-846. PMID 9041245 DOI: 10.1053/Gast.1997.V112.Pm9041245 |
0.343 |
|
| 1997 |
Fasano A, Margaretten K, Uzzau S. Modulation of Intestinal Tight Junctions: A Novel Mechanism of Intestinal Secretion |[dagger]| 482 Pediatric Research. 41: 83-83. DOI: 10.1203/00006450-199704001-00502 |
0.345 |
|
| 1997 |
Fasano A, Uzzau S, Margaretten K. Opening Intestinal Tight Junctions: A Novel Mechanism Of Intestinal Secretion. Journal of Pediatric Gastroenterology and Nutrition. 24: 454. DOI: 10.1097/00005176-199704000-00028 |
0.32 |
|
| 1996 |
Fasano A, Uzzau S, Fiore C, Margaretten K. 4 OPENING INTESTINAL TIGHT JUNCTIONS: A NOVEL MECHANISM OF DIARRHEA.: Oral Presentations Journal of Pediatric Gastroenterology and Nutrition. 23: 343. DOI: 10.1097/00005176-199610000-00034 |
0.306 |
|
| 1996 |
Raimondi F, Karaolis D, Boedeker EC, Kaper JB, Guandalini S, Fasano A. 137 Attaching And Effacing Bacteria Induce An Increase In Tissue Permeability That Is Species-Specific Journal of Pediatric Gastroenterology and Nutrition. 22: 443. DOI: 10.1097/00005176-199605000-00150 |
0.473 |
|
| 1995 |
Fasano A, Fiorentini C, Donelli G, Uzzau S, Kaper JB, Margaretten K, Ding X, Guandalini S, Comstock L, Goldblum SE. Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. Journal of Clinical Investigation. 96: 710-720. PMID 7635964 DOI: 10.1172/Jci118114 |
0.485 |
|
| 1995 |
Raimondi F, Kao JPY, Kaper JB, Guandalini S, Fasano A. Calcium-dependent intestinal chloride secretion by Vibrio parahaemolyticus thermostable direct hemolysin in a rabbit model☆☆☆ Gastroenterology. 109: 381-386. PMID 7615186 DOI: 10.1016/0016-5085(95)90324-0 |
0.498 |
|
| 1995 |
Nataro JP, Seriwatana J, Fasano A, Maneval DR, Guers LD, Noriega F, Dubovsky F, Levine MM, Morris JG. Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and shigella strains Infection and Immunity. 63: 4721-4728. PMID 7591128 DOI: 10.1128/Iai.63.12.4721-4728.1995 |
0.54 |
|
| 1995 |
Raimondi F, Jerse AE, Boedeker EC, Kaper JB, Guandalini S, Rubino A, Fasano A. 68 RET IS A NOVEL ENTEROTOXIN PRODUCED BY RABBIT SPECIFIC EPEC STRAIN RDEC-1 Journal of Pediatric Gastroenterology and Nutrition. 20: 462. DOI: 10.1097/00005176-199505000-00078 |
0.648 |
|
| 1995 |
Raimondi F, Kao JPY, Kaper JB, Guandalini S, Rubino A, Fasano A. 32 CALCIUM MEDIATED INTESTINAL CHLORIDE SECRETION BY THE THERMOSTABLE DIRECT HEMOLYSIN OF VIBRIO PARAHAEMOLYTICUS (Vp) Journal of Pediatric Gastroenterology and Nutrition. 20: 453. DOI: 10.1097/00005176-199505000-00043 |
0.488 |
|
| 1993 |
Michalski J, Galen JE, Fasano A, Kaper JB. CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain. Infection and Immunity. 61: 4462-4468. PMID 8406837 DOI: 10.1128/Iai.61.10.4462-4468.1993 |
0.702 |
|
| 1993 |
Trucksis M, Galen JE, Michalski J, Fasano A, Kaper JB. Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette Proceedings of the National Academy of Sciences of the United States of America. 90: 5267-5271. PMID 8389476 DOI: 10.1073/Pnas.90.11.5267 |
0.709 |
|
| 1993 |
Tacket CO, Losonsky G, Nataro JP, Cryz SJ, Edelman R, Fasano A, Michalski J, Kaper JB, Levine MM. Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae. The Journal of Infectious Diseases. 168: 1536-40. PMID 8245542 DOI: 10.1093/Infdis/168.6.1536 |
0.608 |
|
| 1992 |
Galen JE, Ketley JM, Fasano A, Richardson SH, Wasserman SS, Kaper JB. Role of Vibrio cholerae neuraminidase in the function of cholera toxin. Infection and Immunity. 60: 406-415. PMID 1730470 DOI: 10.1128/Iai.60.2.406-415.1992 |
0.695 |
|
| 1992 |
Nishibuchi M, Fasano A, Russell RG, Kaper JB. Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin. Infection and Immunity. 60: 3539-3545. PMID 1500161 DOI: 10.1128/Iai.60.9.3539-3545.1992 |
0.519 |
|
| 1992 |
Baudry B, Fasano A, Ketley J, Kaper JB. Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae. Infection and Immunity. 60: 428-434. DOI: 10.1128/Iai.60.2.428-434.1992 |
0.507 |
|
| 1992 |
Fasano A, Baundry B, Galen J, Ketley J, Ciarla C, Michalski J, MTnicksls, Guandaltnl S, Kaper J. 50 Vibrio Cholerae (Vc) Elaborates Three Distinct And Yet Interrelated Enterotoxins Journal of Pediatric Gastroenterology and Nutrition. 15: 349. DOI: 10.1097/00005176-199210000-00074 |
0.697 |
|
| 1992 |
Kaper JB, Baudry B, Fasano A, Ketley JM. Characterization of the Vibrio cholerae zot gene encoding a toxin which affects intestinal tight junctions Vaccine. 10: 269. DOI: 10.1016/0264-410X(92)90191-L |
0.521 |
|
| 1991 |
Fasano A, Baudry B, Pumplin DW, Wasserman SS, Tall BD, Ketley JM, Kaper JB. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proceedings of the National Academy of Sciences of the United States of America. 88: 5242-5246. PMID 2052603 DOI: 10.1073/Pnas.88.12.5242 |
0.526 |
|
| 1991 |
Fasano A, Baudry B, Kaper JB, Ciarla C, Ferraro L, Guandalini S. Further Insight Into Production And Diarrheagenicity Of Zonula Occludens Toxin (Zot) By Vibrio Cholerae Journal of Pediatric Gastroenterology and Nutrition. 13: 327. DOI: 10.1097/00005176-199110000-00082 |
0.463 |
|
| 1990 |
Cholerae V, Fasano A, Baudry B, Pumplin DW, Tall BD, Ketley JM, Kaper JB. Production Of A Second Diarrheagenic Factor Pediatric Research. 27: 531-531. DOI: 10.1203/00006450-199005000-00037 |
0.51 |
|
| Show low-probability matches. |